vcanbio cell & gene engineering corp. ltd. (600645.SH) disclosed its third quarter report for 2024, achieving revenue in the first three quarters...
Zhongyuan Xiehe (600645.SH) disclosed its third quarter report for 2024. The company achieved revenue of 1.206 billion yuan in the first three quarters, a year-on-year increase of 0.29%. The net income attributable to shareholders of the listed company was 0.134 billion yuan, a year-on-year increase of 0.76%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.13 billion yuan, a year-on-year increase of 4.18%. The basic earnings per share was 0.29 yuan/share.